サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1412274

遺伝子編集技術市場：提供、技術、用途、エンドユーザー別- 世界予測2024-2030年

Gene Editing Technologies Market by Offering (Reagents & Consumables, Services, Software & Systems), Technology (Antisense, CRISPR, Talen), Application, End User - Global Forecast 2024-2030
出版日: | 発行: 360iResearch | ページ情報: 英文 181 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
遺伝子編集技術市場：提供、技術、用途、エンドユーザー別- 世界予測2024-2030年
出版日: 2024年01月15日
発行: 360iResearch
ページ情報: 英文 181 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

遺伝子編集技術市場規模は2023年に51億2,000万米ドルと推計され、2024年には57億3,000万米ドルに達し、CAGR 12.57%で2030年には117億4,000万米ドルに達すると予測されます。

遺伝子編集技術の世界市場

主な市場の統計
基準年[2023］ 51億2,000万米ドル
予測年[2024］ 57億3,000万米ドル
予測年 [2030] 117億4,000万米ドル
CAGR（%） 12.57%
遺伝子編集技術 Market-IMG1

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは遺伝子編集技術市場を評価する上で極めて重要です。事業戦略と製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、遺伝子編集技術市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1-市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2-市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3-市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4-競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力などを網羅的に評価します。

5-製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています：

1-遺伝子編集技術市場の市場規模および予測は？

2-遺伝子編集技術市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か？

3-遺伝子編集技術市場における技術動向と規制の枠組みは？

4-遺伝子編集技術市場における主要ベンダーの市場シェアは？

5-遺伝子編集技術市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 世界中で遺伝性疾患の有病率が上昇
      • 遺伝子編集の研究開発への投資が増加
      • CRISPRベースのツールの大幅な改善
    • 抑制要因
      • 遺伝子編集技術の開発コストが高い
    • 機会
      • 遺伝子編集技術の技術の進歩
      • 個別化医療アプローチへの傾向
    • 課題
      • 倫理的懸念と厳格な規制枠組み
  • 市場セグメンテーション分析
  • 市場動向分析
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み

第6章 遺伝子編集技術市場：提供別

  • 試薬と消耗品
  • サービス
  • ソフトウェアとシステム

第7章 遺伝子編集技術市場：技術別

  • アンチセンス
  • クリスパー
  • タレン
  • ジンクフィンガーヌクレアーゼ（ZFN）

第8章 遺伝子編集技術市場：用途別

  • 動物遺伝子工学
  • 細胞株工学
  • 遺伝子工学
  • 植物遺伝子工学

第9章 遺伝子編集技術市場：エンドユーザー別

  • 学術および政府の調査機関
  • バイオテクノロジーおよび製薬会社
  • 受託調査機関

第10章 南北アメリカの遺伝子編集技術市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第11章 アジア太平洋地域の遺伝子編集技術市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第12章 欧州・中東・アフリカの遺伝子編集技術市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第13章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析：主要企業別
  • 競合シナリオ主要企業別の分析

第14章 競争力のあるポートフォリオ

  • 主要な企業プロファイル
    • Agilent Technologies, Inc.
    • AMS Biotechnology Ltd.
    • Beam Therapeutics Inc.
    • Caribou Biosciences, Inc.
    • Cellectis SA
    • Creative Biogene
    • CRISPR Therapeutics AG
    • Editas Medicine, Inc.
    • GenScript Biotech Corporation
    • Horizon Discovery Ltd.
    • Inscripta, Inc.
    • Integrated DNA Technologies, Inc.
    • Intellia Therapeutics, Inc.
    • Lonza Group Ltd.
    • Mammoth Biosciences, Inc.
    • Merck Group
    • New England Biolabs, Inc.
    • OriGene Technologies, Inc.
    • Precision BioSciences, Inc.
    • Sangamo Therapeutics, Inc.
    • Synthego Corporation
    • Takara Bio Inc.
    • Tecan Trading AG
    • Thermo Fisher Scientific, Inc.
  • 主要な製品ポートフォリオ

第15章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. GENE EDITING TECHNOLOGIES MARKET RESEARCH PROCESS
  • FIGURE 2. GENE EDITING TECHNOLOGIES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GENE EDITING TECHNOLOGIES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GENE EDITING TECHNOLOGIES MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GENE EDITING TECHNOLOGIES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GENE EDITING TECHNOLOGIES MARKET DYNAMICS
  • FIGURE 7. GENE EDITING TECHNOLOGIES MARKET SIZE, BY OFFERING, 2023 VS 2030 (%)
  • FIGURE 8. GENE EDITING TECHNOLOGIES MARKET SIZE, BY OFFERING, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 10. GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 12. GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 14. GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS GENE EDITING TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. AMERICAS GENE EDITING TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES GENE EDITING TECHNOLOGIES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 18. UNITED STATES GENE EDITING TECHNOLOGIES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC GENE EDITING TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC GENE EDITING TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA GENE EDITING TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA GENE EDITING TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. GENE EDITING TECHNOLOGIES MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 24. GENE EDITING TECHNOLOGIES MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. GENE EDITING TECHNOLOGIES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GENE EDITING TECHNOLOGIES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GENE EDITING TECHNOLOGIES MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 6. GENE EDITING TECHNOLOGIES MARKET SIZE, BY REAGENTS & CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. GENE EDITING TECHNOLOGIES MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. GENE EDITING TECHNOLOGIES MARKET SIZE, BY SOFTWARE & SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 10. GENE EDITING TECHNOLOGIES MARKET SIZE, BY ANTISENSE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GENE EDITING TECHNOLOGIES MARKET SIZE, BY CRISPR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GENE EDITING TECHNOLOGIES MARKET SIZE, BY TALEN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GENE EDITING TECHNOLOGIES MARKET SIZE, BY ZINC FINGER NUCLEASES (ZFN), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 15. GENE EDITING TECHNOLOGIES MARKET SIZE, BY ANIMAL GENETIC ENGINEERING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GENE EDITING TECHNOLOGIES MARKET SIZE, BY CELL LINE ENGINEERING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GENE EDITING TECHNOLOGIES MARKET SIZE, BY GENETIC ENGINEERING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GENE EDITING TECHNOLOGIES MARKET SIZE, BY PLANT GENETIC ENGINEERING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 20. GENE EDITING TECHNOLOGIES MARKET SIZE, BY ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GENE EDITING TECHNOLOGIES MARKET SIZE, BY BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GENE EDITING TECHNOLOGIES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS GENE EDITING TECHNOLOGIES MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS GENE EDITING TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA GENE EDITING TECHNOLOGIES MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL GENE EDITING TECHNOLOGIES MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA GENE EDITING TECHNOLOGIES MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO GENE EDITING TECHNOLOGIES MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES GENE EDITING TECHNOLOGIES MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES GENE EDITING TECHNOLOGIES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC GENE EDITING TECHNOLOGIES MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC GENE EDITING TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA GENE EDITING TECHNOLOGIES MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA GENE EDITING TECHNOLOGIES MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. CHINA GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA GENE EDITING TECHNOLOGIES MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. INDIA GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA GENE EDITING TECHNOLOGIES MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. INDONESIA GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN GENE EDITING TECHNOLOGIES MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. JAPAN GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA GENE EDITING TECHNOLOGIES MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. MALAYSIA GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES GENE EDITING TECHNOLOGIES MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. PHILIPPINES GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE GENE EDITING TECHNOLOGIES MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. SINGAPORE GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA GENE EDITING TECHNOLOGIES MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH KOREA GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN GENE EDITING TECHNOLOGIES MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. TAIWAN GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND GENE EDITING TECHNOLOGIES MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. THAILAND GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM GENE EDITING TECHNOLOGIES MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. VIETNAM GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA GENE EDITING TECHNOLOGIES MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA GENE EDITING TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK GENE EDITING TECHNOLOGIES MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. DENMARK GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT GENE EDITING TECHNOLOGIES MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. EGYPT GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND GENE EDITING TECHNOLOGIES MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. FINLAND GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE GENE EDITING TECHNOLOGIES MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. FRANCE GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY GENE EDITING TECHNOLOGIES MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. GERMANY GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL GENE EDITING TECHNOLOGIES MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. ISRAEL GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY GENE EDITING TECHNOLOGIES MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 134. ITALY GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS GENE EDITING TECHNOLOGIES MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. NETHERLANDS GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA GENE EDITING TECHNOLOGIES MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. NIGERIA GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY GENE EDITING TECHNOLOGIES MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 146. NORWAY GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND GENE EDITING TECHNOLOGIES MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 150. POLAND GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR GENE EDITING TECHNOLOGIES MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 154. QATAR GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA GENE EDITING TECHNOLOGIES MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 158. RUSSIA GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA GENE EDITING TECHNOLOGIES MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 162. SAUDI ARABIA GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA GENE EDITING TECHNOLOGIES MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH AFRICA GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN GENE EDITING TECHNOLOGIES MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 170. SPAIN GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN GENE EDITING TECHNOLOGIES MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 174. SWEDEN GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND GENE EDITING TECHNOLOGIES MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 178. SWITZERLAND GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY GENE EDITING TECHNOLOGIES MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 182. TURKEY GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES GENE EDITING TECHNOLOGIES MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED ARAB EMIRATES GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM GENE EDITING TECHNOLOGIES MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED KINGDOM GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 191. GENE EDITING TECHNOLOGIES MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 192. GENE EDITING TECHNOLOGIES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 193. GENE EDITING TECHNOLOGIES MARKET LICENSE & PRICING
目次
Product Code: MRR-2E76C3E47FDD

[181 Pages Report] The Gene Editing Technologies Market size was estimated at USD 5.12 billion in 2023 and expected to reach USD 5.73 billion in 2024, at a CAGR 12.57% to reach USD 11.74 billion by 2030.

Global Gene Editing Technologies Market

KEY MARKET STATISTICS
Base Year [2023] USD 5.12 billion
Estimated Year [2024] USD 5.73 billion
Forecast Year [2030] USD 11.74 billion
CAGR (%) 12.57%
Gene Editing Technologies Market - IMG1

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Gene Editing Technologies Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Gene Editing Technologies Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Gene Editing Technologies Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., AMS Biotechnology Ltd., Beam Therapeutics Inc., Caribou Biosciences, Inc., Cellectis SA, Creative Biogene, CRISPR Therapeutics AG, Editas Medicine, Inc., GenScript Biotech Corporation, Horizon Discovery Ltd., Inscripta, Inc., Integrated DNA Technologies, Inc., Intellia Therapeutics, Inc., Lonza Group Ltd., Mammoth Biosciences, Inc., Merck Group, New England Biolabs, Inc., OriGene Technologies, Inc., Precision BioSciences, Inc., Sangamo Therapeutics, Inc., Synthego Corporation, Takara Bio Inc., Tecan Trading AG, and Thermo Fisher Scientific, Inc..

Market Segmentation & Coverage

This research report categorizes the Gene Editing Technologies Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Offering
    • Reagents & Consumables
    • Services
    • Software & Systems
  • Technology
    • Antisense
    • CRISPR
    • Talen
    • Zinc Finger Nucleases (ZFN)
  • Application
    • Animal Genetic Engineering
    • Cell Line Engineering
    • Genetic Engineering
    • Plant Genetic Engineering
  • End User
    • Academic & Government Research Institutes
    • Biotechnology & Pharmaceutical Companies
    • Contract Research Organizations
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Gene Editing Technologies Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Gene Editing Technologies Market?

3. What are the technology trends and regulatory frameworks in the Gene Editing Technologies Market?

4. What is the market share of the leading vendors in the Gene Editing Technologies Market?

5. Which modes and strategic moves are suitable for entering the Gene Editing Technologies Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Gene Editing Technologies Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of genetic disorders worldwide
      • 5.1.1.2. Increasing investments for R&D in gene editing
      • 5.1.1.3. Significant improvements in CRISPR-based tools
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of development of gene editing technologies
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements in gene editing technologies
      • 5.1.3.2. Inclination toward personalized medicine approach
    • 5.1.4. Challenges
      • 5.1.4.1. Ethical concerns and stringent regulatory framework
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Gene Editing Technologies Market, by Offering

  • 6.1. Introduction
  • 6.2. Reagents & Consumables
  • 6.3. Services
  • 6.4. Software & Systems

7. Gene Editing Technologies Market, by Technology

  • 7.1. Introduction
  • 7.2. Antisense
  • 7.3. CRISPR
  • 7.4. Talen
  • 7.5. Zinc Finger Nucleases (ZFN)

8. Gene Editing Technologies Market, by Application

  • 8.1. Introduction
  • 8.2. Animal Genetic Engineering
  • 8.3. Cell Line Engineering
  • 8.4. Genetic Engineering
  • 8.5. Plant Genetic Engineering

9. Gene Editing Technologies Market, by End User

  • 9.1. Introduction
  • 9.2. Academic & Government Research Institutes
  • 9.3. Biotechnology & Pharmaceutical Companies
  • 9.4. Contract Research Organizations

10. Americas Gene Editing Technologies Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Gene Editing Technologies Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Gene Editing Technologies Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. FPNV Positioning Matrix
  • 13.2. Market Share Analysis, By Key Player
  • 13.3. Competitive Scenario Analysis, By Key Player

14. Competitive Portfolio

  • 14.1. Key Company Profiles
    • 14.1.1. Agilent Technologies, Inc.
    • 14.1.2. AMS Biotechnology Ltd.
    • 14.1.3. Beam Therapeutics Inc.
    • 14.1.4. Caribou Biosciences, Inc.
    • 14.1.5. Cellectis SA
    • 14.1.6. Creative Biogene
    • 14.1.7. CRISPR Therapeutics AG
    • 14.1.8. Editas Medicine, Inc.
    • 14.1.9. GenScript Biotech Corporation
    • 14.1.10. Horizon Discovery Ltd.
    • 14.1.11. Inscripta, Inc.
    • 14.1.12. Integrated DNA Technologies, Inc.
    • 14.1.13. Intellia Therapeutics, Inc.
    • 14.1.14. Lonza Group Ltd.
    • 14.1.15. Mammoth Biosciences, Inc.
    • 14.1.16. Merck Group
    • 14.1.17. New England Biolabs, Inc.
    • 14.1.18. OriGene Technologies, Inc.
    • 14.1.19. Precision BioSciences, Inc.
    • 14.1.20. Sangamo Therapeutics, Inc.
    • 14.1.21. Synthego Corporation
    • 14.1.22. Takara Bio Inc.
    • 14.1.23. Tecan Trading AG
    • 14.1.24. Thermo Fisher Scientific, Inc.
  • 14.2. Key Product Portfolio

15. Appendix

  • 15.1. Discussion Guide
  • 15.2. License & Pricing